About Eidos Therapeutics & BridgeBio Pharma

Eidos Therapeutics, an affiliate of BridgeBio Pharma, is a Phase 3 developmental-stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin, or TTR, amyloidosis, or ATTR. We seek to treat this well-defined family of diseases at their collective source by stabilizing TTR. Our investigational product, acoramidis (AG10), is an orally administered small molecule designed to potently stabilize TTR, a potentially best-in-class treatment aiming to halt the progression of ATTR diseases.

BridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genetic science in academic institutions and the delivery of meaningful medicines to patients. Founded in 2015, the company has built a portfolio of 30+ drug development programs ranging from preclinical to late-stage development in multiple therapeutic areas including genetic dermatology, precision oncology, cardiology, endocrinology, neurology, pulmonology, and renal disease, with two approved drugs. 

Our focus on scientific excellence and rapid execution aims to translate today’s discoveries into tomorrow’s medicines. We have U.S. offices in San Francisco, Palo Alto, and Raleigh, with small satellites in other parts of the country. We also have international offices in Montreal, Canada, and Zurich, Switzerland, and are expanding across Europe. 

To learn more about our story and company culture, visit us at eidostx.com/ | https://bridgebio.com

Who You Are

The Sr. Medical Science Liaison (MSL) is a field-based scientific expert responsible for communicating with various internal and external stakeholders, providing medical and scientific information on the appropriate utilization of therapy(s), and advancing therapeutic disease state knowledge. The Sr. Medical Science Liaison is a core member of the Medical Affairs Team, leveraging a scientific approach that is aligned with medical affairs objectives and therapeutic area medical plans. 

The Sr. Medical Science Liaison will be experienced working in a fast-paced, highly collaborative environment, specifically with product launch planning, rare disorders, or underdiagnosed patient populations.  This includes developing and executing a comprehensive territory medical plan, attending conferences, delivering scientific presentations, and scientific exchange with physicians and other healthcare providers.  A critical part of this role will be cultivating relationships and establishing professional collaborations with academic researchers, therapeutic area leaders, relevant research centers, organizations, and clinical care teams.

This position reports to the Regional Field MSL Director and will require extensive travel, sometimes involving weekends.

Central Region - MO, IA, NE, KS, CO, and UT. 

Responsibilities

• Developing relationships with various healthcare professionals and providing them with credible, fair, balanced, scientific information
• Be a major source of balanced medical information for HCPs and will be skilled in issues management and addressing unsolicited questions about safety and off-label use of products based on available scientific data
• Territory planning, identifying new external stakeholders, and understanding therapeutic area educational and data gaps in the community will be key activities. This plan may be dynamic with respect to the molecule, molecule life-cycle, therapeutic area, and territory. The Senior MSL will liaise with key internal stakeholders to build a comprehensive action-oriented plan
• Expected to become a therapeutic area and product expert. This will be evidenced by regular review of relevant literature and participation in scientific congresses and conferences, including training sessions, to establish and maintain an up-to-date knowledge base
• Be instrumental in internal training and communication. Knowledge sharing, including KOL and site profiling, and education both internally and externally will be a key area of responsibility
• Assist in the identification of potential investigators and research projects. This may include assistance with investigator-sponsored trial process, sponsored study site identification, recruitment strategies, and collaboration with clinical operations

No matter your role at BridgeBio, successful team members are:

• Patient Champions, who put patients first and uphold strict ethical standards
• Entrepreneurial Operators, who drive toward practical solutions and have an ownership mindset
• Truth Seekers, who are detailed, rational, and humble problem solvers
• Individuals Who Inspire Excellence in themselves and those around them
• High-quality executors, who execute against goals and milestones with quality, precision, and speed

Education, Experience & Skills Requirements

• Candidates with a PharmD, Ph.D., MD, Genetic Counseling, as well as other advanced healthcare degrees or relevant experience, will be considered
• 3+ years of medical affairs or field medical experience with a verifiable record of high performance
• Prior experience in rare diseases, cardiology, or neurology is preferred
• Excellent interpersonal communication and presentation skills (including networking)
• Able to participate in a scientific dialogue with KOL’s and researchers
• Excellent teaching skills and ability to present and discuss scientific material clearly and concisely
• Proven ability to create and sustain relationships with industry leaders
• Skilled in clinical research and an understanding of the process of pharmaceutical product development and approval
• Demonstrated ability to organize, prioritize, and work effectively with minimal supervision in a constantly changing environment
• Travel 50-60% of the time depending on territory size; evening and weekend work will be involved with some variation based upon the demands of the business imperatives

What We Offer

• Patient Days, where we are fortunate to hear directly from individuals living with the conditions we are seeking to impact throughout the year and learn how we can improve our efforts
• A culture inspired by our values: put patients first, think independently, be radically transparent, every minute counts, and let the science speak
• An unyielding commitment to always putting patients first. Learn more about how we do this here
• A de-centralized model that enables our program teams to focus on advancing science and helping patients. Our affiliate structure is designed to eliminate bureaucracy and put decision-making power in the hands of those closest to the science
• A place where you own the vision – both for your program and your own career path
• A collaborative, fast-paced, data-driven environment where we inspire ourselves and each other to always perform at the top of our game
• Access to learning and development resources to help you get in the best professional shape of your life
• Robust and market-competitive compensation & benefits package (Base, Performance Bonus, Equity, health, welfare & retirement programs)
• Flexible PTO
• Rapid career advancement for strong performers
• Potential ability to work on multiple BridgeBio Pharma programs across multiple therapeutic areas over time 
• Partnerships with leading institutions
• Commitment to Diversity, Equity & Inclusion